Insights

Innovative Product Pipeline Inbiose specializes in developing structurally identical Human Milk Oligosaccharides that are sustainably produced via fermentation, offering a cost-effective supply of high-demand, health-critical ingredients that appeal to infant nutrition, cosmetics, and beyond markets.

Strategic Industry Collaborations The company's partnership with DuPont Nutrition & Health to develop and commercialize complex carbohydrates demonstrates their strong position in collaborative innovation, opening opportunities to connect with other global biotech and nutrition firms seeking advanced carbohydrate solutions.

Growing Financial Support With €15 million in funding from the European Investment Bank, Inbiose is positioned for further expansion and product development, making it easier to target prospects interested in innovative biotech solutions with proven financial backing.

Market Focus & Expansion Inbiose's focus on specialty oligosaccharides for human health, infant nutrition, and cosmetics creates multiple entry points for selling innovative ingredients to food, supplement, skincare, and nutraceutical companies seeking bio-based health solutions.

Technological Edge Utilizing advanced fermentation processes, high-throughput development, and process scale-up capabilities, Inbiose offers a competitive advantage for clients looking to efficiently develop and scale novel carbohydrate-based ingredients for health-focused products.

Inbiose Tech Stack

Inbiose uses 8 technology products and services including Open Graph, MySQL, Microsoft 365, and more. Explore Inbiose's tech stack below.

  • Open Graph
    Content Management System
  • MySQL
    Database
  • Microsoft 365
    Email
  • jQuery
    Javascript Libraries
  • Microsoft Word
    Office Suites
  • Webflow
    Page Builders
  • Microsoft Teams
    Team Collaboration
  • Plyr
    Video Players

Inbiose's Email Address Formats

Inbiose uses at least 1 format(s):
Inbiose Email FormatsExamplePercentage
First.Last@inbiose.comJohn.Doe@inbiose.com
81%
Last@inbiose.comDoe@inbiose.com
10%
First.MiddleLast@inbiose.comJohn.MichaelDoe@inbiose.com
8%
First.Middle@inbiose.comJohn.Michael@inbiose.com
1%

Frequently Asked Questions

Where is Inbiose's headquarters located?

Minus sign iconPlus sign icon
Inbiose's main headquarters is located at Zwijnaarde, Flanders 9052 Belgium. The company has employees across 1 continents, including Europe.

What is Inbiose's official website and social media links?

Minus sign iconPlus sign icon
Inbiose's official website is inbiose.com and has social profiles on LinkedInCrunchbase.

What is Inbiose's SIC code NAICS code?

Minus sign iconPlus sign icon
Inbiose's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Inbiose have currently?

Minus sign iconPlus sign icon
As of May 2026, Inbiose has approximately 60 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: D. A.Chief Financial Officer: B. F.Chief Operating Officer: J. S.. Explore Inbiose's employee directory with LeadIQ.

What industry does Inbiose belong to?

Minus sign iconPlus sign icon
Inbiose operates in the Biotechnology Research industry.

What technology does Inbiose use?

Minus sign iconPlus sign icon
Inbiose's tech stack includes Open GraphMySQLMicrosoft 365jQueryMicrosoft WordWebflowMicrosoft TeamsPlyr.

What is Inbiose's email format?

Minus sign iconPlus sign icon
Inbiose's email format typically follows the pattern of First.Last@inbiose.com. Find more Inbiose email formats with LeadIQ.

How much funding has Inbiose raised to date?

Minus sign iconPlus sign icon
As of May 2026, Inbiose has raised $18M in funding. The last funding round occurred on Jul 14, 2021 for $18M.

When was Inbiose founded?

Minus sign iconPlus sign icon
Inbiose was founded in 2013.

Inbiose

Biotechnology ResearchFlanders, Belgium51-200 Employees

“Dedicated to specialty carbohydrates for human health and beyond”

Inbiose is dedicated to improving human health by making specialty oligosaccharides available for mainstream use. We strive to make available to the consumer the health benefits these complex sugars can bring to human and infant health, as well as specialized nutrition, cosmetics and beyond.

Inbiose is a leading company in the development of Human Milk Oligosaccharides, which are of paramount importance for the health of newborns and developing infants.

Our competences lie in the rapid development and cost-effective production of innovative specialty carbohydrates otherwise unavailable to society at large.

Our development pipeline allows us to offer a high-throughput development platform, as well as process development, scale-up and regulatory services that compressing new product development cycles and minimizes time to market.

Section iconCompany Overview

Headquarters
Zwijnaarde, Flanders 9052 Belgium
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $18M

    Inbiose has raised a total of $18M of funding over 1 rounds. Their latest funding round was raised on Jul 14, 2021 in the amount of $18M.

  • $1M

    Inbiose's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $18M

    Inbiose has raised a total of $18M of funding over 1 rounds. Their latest funding round was raised on Jul 14, 2021 in the amount of $18M.

  • $1M

    Inbiose's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.